Inovio Stock Future Price Prediction

INO
 Stock
  

USD 1.73  0.05  2.98%   

Inovio Pharma stock price prediction is an act of determining the future value of Inovio Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Inovio Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Inovio Pharma and does not consider all of the tangible or intangible factors available from Inovio Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Inovio Pharma, which may create opportunities for some arbitrage if properly timed.
Please see Inovio Pharma Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Inovio Pharma based on different types of headlines from major news networks to social media. The Inovio stock price prediction module provides an analysis of price elasticity to changes in media outlook on Inovio Pharma over a specific investment horizon.Using Inovio Pharma hype-based prediction, you can estimate the value of Inovio Pharma from the perspective of Inovio Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Inovio Pharma using Inovio Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Inovio using crowd psychology based on the activity and movement of Inovio Pharma's stock price.

Inovio Pharma Implied Volatility

    
  199.27  
Inovio Pharma's implied volatility exposes the market's sentiment of Inovio Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Inovio Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Inovio Pharma stock will not fluctuate a lot when Inovio Pharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Inovio Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Inovio Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Inovio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Inovio Pharma after-hype prediction price

    
  $ 1.77  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inovio Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inovio Pharma in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.244.7710.94
Details
Naive
Forecast
LowNext ValueHigh
0.0352551.767.93
Details
8 Analysts
Consensus
LowTarget PriceHigh
6.0013.6235.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.552.082.60
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inovio Pharma. Your research has to be compared to or analyzed against Inovio Pharma's peers to derive any actionable benefits. When done correctly, Inovio Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inovio Pharma.

Inovio Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Inovio Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Inovio Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Inovio Pharma, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Inovio Pharma Estimiated After-Hype Price Volatility

In the context of predicting Inovio Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Inovio Pharma's historical news coverage. Inovio Pharma's after-hype downside and upside margins for the prediction period are 0.09 and 7.94, respectively. We have considered Inovio Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 1.73
1.77
After-hype Price
7.94
Upside
Inovio Pharma is risky asset. Analysis and calculation of next after-hype price of Inovio Pharma is based on 3 months time horizon.

Inovio Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Inovio Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inovio Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Inovio Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.10  6.17  0.04   0.03  6 Events / Month4 Events / MonthIn about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.731.772.31 
1,624  

Inovio Pharma Hype Timeline

On the 1st of October Inovio Pharma is traded for 1.73. The entity has historical hype elasticity of 0.04 and average elasticity to hype of competition of 0.03. Inovio is estimated to increase in value after the next headline with the price projected to jump to 1.77 or above. The average volatility of media hype impact on the company stock price is over 100%. The price upswing on the next news is forecasted to be 2.31% whereas the daily expected return is currently at -0.1%. The volatility of related hype on Inovio Pharma is about 1979.68% with expected price after next announcement by competition of 1.76. The company has 33.65 M in debt with debt to equity (D/E) ratio of 0.09, which may show that the company is not taking advantage of profits from borrowing. Considering the 90-day investment horizon the next estimated press release will be in about 6 days.
Please see Inovio Pharma Basic Forecasting Models to cross-verify your projections.

Inovio Pharma Related Hype Analysis

Having access to credible news sources related to Inovio Pharma's direct competition is more important than ever and may enhance your ability to predict Inovio Pharma's future price movements. Getting to know how Inovio Pharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Inovio Pharma may potentially react to the hype associated with one of its peers.

Inovio Pharma Additional Predictive Modules

Most predictive techniques to examine Inovio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Inovio using various technical indicators. When you analyze Inovio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Inovio Pharma Predictive Indicators

The successful prediction of Inovio Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Inovio Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Inovio Pharma based on analysis of Inovio Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Inovio Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Inovio Pharma's related companies.

Story Coverage note for Inovio Pharma

The number of cover stories for Inovio Pharma depends on current market conditions and Inovio Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Inovio Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Inovio Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Inovio Pharma Short Properties

Inovio Pharma's future price predictability will typically decrease when Inovio Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Inovio Pharma often depends not only on the future outlook of the potential Inovio Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inovio Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out18.98%
Short Percent Of Float19.30%
Float Shares225.14M
Shares Short Prior Month35.91M
Average Daily Volume Last 10 Day6.06M
Average Daily Volume In Three Month5.84M
Date Short Interest15th of July 2022
Please see Inovio Pharma Basic Forecasting Models to cross-verify your projections. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for analysis

When running Inovio Pharma price analysis, check to measure Inovio Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharma is operating at the current time. Most of Inovio Pharma's value examination focuses on studying past and present price action to predict the probability of Inovio Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inovio Pharma's price. Additionally, you may evaluate how the addition of Inovio Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Is Inovio Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharma. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Inovio Pharma is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharma's value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharma's market value can be influenced by many factors that don't directly affect Inovio Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Inovio Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.